Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
![]() |
|||||
GSE236728 |
Synthetic essentiality of thymine DNA glycosylase in p53-deficient cancer
|
|
|
65 | Zhenyu Shao | Jun 19, 2024 | ||
GSE230602 |
Overcoming Lineage Plasticity and AR-Targeted Therapy Resistance in ZNF397-Deficient Prostate Cancer via TET2 Inhibition
|
|
51 | Ping Mu | Apr 05, 2024 | |||
GSE197569 |
Aberrant DNA methylation distorts developmental trajectories in atypical teratoid/rhabdoid tumors
|
|
31 |
|
Kirsi Rautajoki | Mar 04, 2024 | ||
GSE230405 |
TDP-43 stable deficiency leads to transcriptional dysregulation and transposable elements activation via global R-loops and 5hmC landscape alteration [5hmC-Seal-seq]
|
|
7 | Bing Yao | Jan 03, 2024 | |||
GSE230410 |
TDP-43 stable deficiency leads to transcriptional dysregulation and transposable elements activation via global R-loops and 5hmC landscape alteration
|
|
32 | Bing Yao | Jan 03, 2024 | |||
GSE240438 |
Epitranscriptome profiling of m6A in colon cancer cell lines
|
|
10 |
|
Samson Mani | Dec 30, 2023 | ||
GSE213771 |
ATAC-seq, RNA-seq and RRBS of TET2-mutant human neutrophils
|
|
20 |
|
Dominique Bonnet | Dec 01, 2023 | ||
GSE231834 |
N6-methyladenosine RNA modification drives a rapid shift to cisplatin resistance in bladder cancer by regulating SLC7A11 expression via YTHDF3 [RIP-seq]
|
|
20 | Emmanuelle Hodara | Nov 08, 2023 | |||
GSE231836 |
N6-methyladenosine RNA modification drives a rapid shift to cisplatin resistance in bladder cancer by regulating SLC7A11 expression via YTHDF3
|
|
30 | Emmanuelle Hodara | Nov 08, 2023 | |||
GSE211588 |
CFL1-induced super enhancer RNA m6A modification promotes local chromatin accessibility and oncogenes transcription in pancreatic cancer [m6A-seq]
|
|
32 |
|
Rui Li | Sep 20, 2023 | ||
GSE214550 |
Multiplex Epigenome Editing of MECP2 to Rescue Rett Syndrome Neurons II
|
|
24 | Xiaonan Guan | Sep 01, 2023 | |||
GSE221053 |
Transposable elements as lineage-specific enhancers in endodermal-lineage cancers
|
|
30 | Konsta Karttunen | Aug 11, 2023 | |||
GSE228707 |
Bisulfite-free base-resolution sequencing of oxidized cytosines (APOBEC-seq) reveals a ubiquitous role of thymine DNA glycosylase in active gene promoters and an interaction with MBD3/NuRD
|
|
|
55 |
|
Moshe Szyf | Jun 30, 2023 | |
GSE153696 |
Age associated epigenome changes in human mammary epithelial cells
|
|
26 |
|
Parijat Senapati | Jun 09, 2023 | ||
GSE206968 |
N6-methyladenosine-enhanced FZR1 translation contributes to gemcitabine insensitivity in pancreatic cancer via quiescence maintenance [m6A-seq]
|
|
12 | Rui Li | Jun 09, 2023 | |||
GSE206969 |
N6-methyladenosine modification of FZR1 mRNA promotes gemcitabine resistance in pancreatic cancer
|
|
15 |
|
Rui Li | Jun 08, 2023 | ||
GSE176533 |
MeRIP-sequencing for dynamic epi-transcriptomic landscape mapping with disease progression in ER-positive breast cancer
|
|
8 |
|
Leonie Young | May 16, 2023 | ||
GSE193201 |
Reprogramming of human peripheral blood mononuclear cells into induced mesenchymal stromal cells
|
|
30 | Charles Wang | Mar 22, 2023 | |||
GSE221753 |
Translocation t(6;7) in AML-M4 cell line GDM-1 results in MNX1 activation through enhancer-hijacking
|
|
14 | Christoph Plass | Feb 27, 2023 | |||
GSE182017 |
Pluripotency-Independent Induction of Human Trophoblast Stem Cells from Fibroblasts
|
|
114 | Yosef Buganim | Feb 21, 2023 |